Aytu BioPharma Inc. (AYTU) NASDAQ

$0.20 0.01 (6.79%)

Market Cap: $11.86M

As of 10/04/22 04:00 PM EDT. Market closed.

(AYTU)

Aytu BioPharma Inc. (AYTU) NASDAQ

$0.20 0.01 (6.79%)

Market Cap: $11.86M

As of 10/04/22 04:00 PM EDT. Market closed.

Aytu BioScience is a commercial-stage specialty pharmaceutical company focused on commercializing novel products that address significant patient needs. Aytu currently markets a portfolio of prescription products addressing large primary care and pediatric markets. The portfolio includes Natesto®, the only FDA-approved nasal formulation of testosterone for men with hypogonadism (low ... read more

Aytu BioScience is a commercial-stage specialty pharmaceutical company focused on commercializing novel products that address significant patient needs. Aytu currently markets a portfolio of prescription products addressing large primary care and pediatric markets. The portfolio includes Natesto®, the only FDA-approved nasal formulation of testosterone for men with hypogonadism (low testosterone, or 'Low T'), ZolpiMist®, the only FDA-approved oral spray prescription sleep aid, Tuzistra® XR, the only FDA-approved 12-hour codeine-based antitussive syrup, Karbinal® ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions, and Poly-Vi-Flor® and Tri-Vi-Flor®, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency. Aytu also distributes a COVID-19 IgG/IgM rapid antibody test and a rapid COVID-19 antigen test. These tests are used separately in the rapid, qualitative diagnostic assessment of the 2019 Novel Coronavirus. Additionally, Aytu has licensed worldwide rights to develop the Healight™ technology platform. Healight is an investigational medical device being studied as a prospective treatment for COVID-19 and other respiratory infections. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
16200 W County Road 18 E, Colorado, Loveland, 80537-9715.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
75
Address
16200 W County Road 18 E, Colorado, Loveland, 80537-9715.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$0.19
Previous Close
$0.19
Days Range
$0.17 - $0.19
52 week range
$0.17 - $2.82
Volume
1,252,937
Avg. Volume (30 days)
1,100,640
Market Cap
$11.86M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
62,432,727
Open
$0.19
Previous Close
$0.19
Days Range
$0.17 - $0.19
52 week range
$0.17 - $2.82
Volume
1,252,937
Avg. Volume (30 days)
1,100,640
Market Cap
$11.86M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
62,432,727

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AYTU BIOPHARMA INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
ARMISTICE CAPITAL, LLC Director Dec 11, 2020 Buy $6.00 1,333,334 8,000,004 1,333,334 Dec 15, 2020, 07:17 PM
ARMISTICE CAPITAL, LLC Director Apr 27, 2020 Option Exercise $1.25 5,000,000 6,250,000 5,108,921 Apr 29, 2020, 08:22 PM
ARMISTICE CAPITAL, LLC Director Apr 27, 2020 Sale $1.82 5,108,921 9,298,236 0 Apr 29, 2020, 08:22 PM
Cerecor Inc. 10% Owner Apr 15, 2020 Sale $1.55 92,777 144,092 9,713,068 Apr 27, 2020, 09:30 AM
ARMISTICE CAPITAL, LLC Director Mar 10, 2020 Option Exercise $1.30 1,487,639 1,933,931 18,119,637 Mar 12, 2020, 07:49 PM
ARMISTICE CAPITAL, LLC Director Mar 10, 2020 Option Exercise $1.15 13,310,574 15,264,157 22,026,802 Mar 12, 2020, 07:49 PM
ARMISTICE CAPITAL, LLC Director Mar 10, 2020 Sale $1.42 22,026,801 31,200,123 2,456,823 Mar 12, 2020, 07:49 PM
ARMISTICE CAPITAL, LLC Director Dec 19, 2019 Buy $0.85 52,788 44,870 7,924,000 Dec 23, 2019, 10:10 AM
ARMISTICE CAPITAL, LLC Director Dec 20, 2019 Buy $0.88 26,000 22,880 7,950,000 Dec 23, 2019, 10:10 AM
Disbrow Joshua R. Chief Executive Officer Dec 19, 2019 Buy $0.89 55,000 48,824 525,048 Dec 19, 2019, 03:10 PM
ARMISTICE CAPITAL, LLC Director Oct 30, 2019 Option Exercise $0.88 2,751,148 2,421,010 7,871,212 Nov 01, 2019, 05:15 PM
Green David A Chief Financial Officer Feb 13, 2019 Option Exercise $1.04 5,000 5,189 271,250 Feb 15, 2019, 04:45 PM
Green David A Chief Financial Officer Dec 21, 2018 Sale $0.81 3,330 2,711 266,250 Dec 26, 2018, 04:00 PM
Disbrow Joshua R. Chief Executive Officer Mar 06, 2018 Buy $0.45 226,105 101,747 490,949 Mar 07, 2018, 04:39 PM
Green David A Chief Financial Officer Mar 06, 2018 Buy $0.45 66,600 29,970 141,600 Mar 07, 2018, 04:38 PM
Disbrow Jarrett Chief Operating Officer Mar 06, 2018 Buy $0.45 226,105 101,747 439,490 Mar 07, 2018, 04:36 PM
Disbrow Jarrett Chief Operating Officer Aug 15, 2017 Option Exercise $0.15 1,666,667 250,000 2,267,671 Aug 22, 2017, 07:58 PM
Disbrow Joshua R. Chief Executive Officer Aug 15, 2017 Option Exercise $0.15 1,666,667 250,000 2,296,861 Aug 22, 2017, 07:55 PM
Cantrell Gary Director Feb 27, 2017 Option Exercise $0.75 37,083 27,812 135,416 Mar 08, 2017, 04:40 PM
Gould Gregory A Chief Financial Officer Feb 27, 2017 Option Exercise $0.75 66,666 50,000 340,231 Mar 01, 2017, 07:33 PM
DOCKERY CARL Director Feb 27, 2017 Option Exercise $0.75 416,667 312,500 837,300 Mar 01, 2017, 07:03 PM
Cantrell Gary Director Feb 27, 2017 Option Exercise $0.75 37,083 27,812 135,416 Mar 01, 2017, 06:47 PM
Disbrow Jarrett Chief Operating Officer Feb 27, 2017 Option Exercise $0.75 187,500 140,625 601,004 Mar 01, 2017, 06:43 PM
Disbrow Joshua R. Chief Executive Officer Feb 27, 2017 Option Exercise $0.75 187,500 140,625 630,194 Mar 01, 2017, 06:41 PM
Cantrell Gary Director Nov 02, 2016 Buy $1.50 33,333 50,000 98,333 Nov 04, 2016, 04:58 PM
Gould Gregory A Chief Financial Officer Nov 02, 2016 Buy $1.50 66,666 99,999 273,565 Nov 04, 2016, 04:58 PM
Disbrow Jarrett Chief Operating Officer Nov 02, 2016 Buy $1.50 166,666 249,999 413,504 Nov 04, 2016, 04:57 PM
Disbrow Joshua R. Chief Executive Officer Nov 02, 2016 Buy $1.50 166,666 249,999 442,694 Nov 04, 2016, 04:57 PM
DOCKERY CARL Director May 06, 2016 Buy $0.40 5,000,000 2,000,000 5,047,591 May 16, 2016, 04:17 PM
Disbrow Joshua R. Chief Executive Officer May 06, 2016 Buy $0.40 250,000 100,000 403,846 May 16, 2016, 04:15 PM
Disbrow Jarrett Chief Operating Officer May 06, 2016 Buy $0.40 250,000 100,000 403,846 May 16, 2016, 04:14 PM
Disbrow Joshua R. Chief Executive Officer Jan 20, 2016 Buy $0.65 153,846 100,000 153,846 Jan 21, 2016, 04:13 PM
Disbrow Jarrett Chief Operating Officer Jan 20, 2016 Buy $0.65 153,846 100,000 153,846 Jan 21, 2016, 04:11 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
ARMISTICE CAPITAL, LLC Director 12/11/2020 8,000,004
ARMISTICE CAPITAL, LLC Director 04/27/2020 6,250,000
ARMISTICE CAPITAL, LLC Director 04/27/2020 9,298,236
Cerecor Inc. 10% Owner 04/15/2020 144,092
ARMISTICE CAPITAL, LLC Director 03/10/2020 1,933,931
ARMISTICE CAPITAL, LLC Director 03/10/2020 15,264,157
ARMISTICE CAPITAL, LLC Director 03/10/2020 31,200,123
ARMISTICE CAPITAL, LLC Director 12/19/2019 44,870
ARMISTICE CAPITAL, LLC Director 12/20/2019 22,880
Disbrow Joshua R. Chief Executive Officer 12/19/2019 48,824
ARMISTICE CAPITAL, LLC Director 10/30/2019 2,421,010
Green David A Chief Financial Officer 02/13/2019 5,189
Green David A Chief Financial Officer 12/21/2018 2,711
Disbrow Joshua R. Chief Executive Officer 03/06/2018 101,747
Green David A Chief Financial Officer 03/06/2018 29,970
Disbrow Jarrett Chief Operating Officer 03/06/2018 101,747
Disbrow Jarrett Chief Operating Officer 08/15/2017 250,000
Disbrow Joshua R. Chief Executive Officer 08/15/2017 250,000
Cantrell Gary Director 02/27/2017 27,812
Gould Gregory A Chief Financial Officer 02/27/2017 50,000
DOCKERY CARL Director 02/27/2017 312,500
Cantrell Gary Director 02/27/2017 27,812
Disbrow Jarrett Chief Operating Officer 02/27/2017 140,625
Disbrow Joshua R. Chief Executive Officer 02/27/2017 140,625
Cantrell Gary Director 11/02/2016 50,000
Gould Gregory A Chief Financial Officer 11/02/2016 99,999
Disbrow Jarrett Chief Operating Officer 11/02/2016 249,999
Disbrow Joshua R. Chief Executive Officer 11/02/2016 249,999
DOCKERY CARL Director 05/06/2016 2,000,000
Disbrow Joshua R. Chief Executive Officer 05/06/2016 100,000
Disbrow Jarrett Chief Operating Officer 05/06/2016 100,000
Disbrow Joshua R. Chief Executive Officer 01/20/2016 100,000
Disbrow Jarrett Chief Operating Officer 01/20/2016 100,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2022
12/31/2021
13.05%
2Q
06/30/2022
09/30/2021
14.85%
3Q
06/30/2022
06/30/2020
-34.95%
8Q
06/30/2022
03/31/2020
29.98%
9Q
Load More

Period of Report: 06/30/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2021
13.05%
2Q
09/30/2021
14.85%
3Q
06/30/2020
-34.95%
8Q
03/31/2020
29.98%
9Q
Load More